Serial #79079371
LIVE

Serial Number

79079371

Owner

CELLTRION, INC.

Filing Date

Nov 10, 2009

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79079371 Trademark

Serial Number: 79079371 • Registration: 3936765

Serial #79079371 is a trademark filed by CELLTRION, INC. on November 10, 2009. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

CELLTRION, INC. (115 trademarks)

23, Academy-ro,

Entity Type: 03

Celltrion Holdings Co.,Ltd. (15 trademarks)

5th, 19, Academy-ro 51beon-gil,
Incheon 22014 , KR

Entity Type: 03

Trademark Details

Filing Date

November 10, 2009

Registration Date

March 29, 2011

Published for Opposition

January 11, 2011

Goods & Services

Treatment of biopharmaceutical materials, namely, processing finished products from raw biopharmaceutical materials; treatment service of biopharmaceutical materials for others, namely, processing finished products from raw biopharmaceutical materials for others; contract manufacturing service for others in the field of biopharmaceuticals; contract manufacturing service in the field of pharmaceuticals

[ Vaccines; medicines for sensory organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of sensory organ; agents affecting peripheral nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the peripheral nervous system; agents for immunity adjustment, namely, pharmaceutical preparations for the prevention and treatment of disorders of the immune system; biological preparations for medical purposes; amino acids for medical purposes; antibiotic preparations; agents for respiratory organs, namely, pharmaceutical preparations for the prevention and treatment of disorders of respiratory organs; chemotherapeutics; reagents for measuring Hepatitis B Surface antibody, namely, medical diagnostic reagents for detecting Hepatitis B surface antibody; diagnostic preparations for medical use; AIDS, acquired immune deficiency syndrome diagnostic agents, namely, diagnostic preparation for medical use; AIDS, acquired immune deficiency syndrome vaccines; agents affecting central nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the nervous system; veterinary vaccines; agents for tumor treatment, namely, pharmaceutical preparations for the treatment of tumor; agents for urogenital organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of urogenital organs; kits for protein test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a protein related to a disease; kits for gene test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a gene related to a disease; biopharmaceuticals for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; biopharmaceutical preparations, namely, polypeptides, proteins, monoclonal antibodies, hormones for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone deficiency diseases; biotherapeutic preparations and substances for medical purposes; biotechnological preparations for medical purposes; pharmaceuticals; chemical preparations for pharmaceutical purposes, namely, chemical reagents for medical purposes; chemico-pharmaceutical preparations ]

Wholesale distributorships featuring pharmaceutical products; retail store services featuring pharmaceutical products; business intermediary services in the field of pharmaceutical products; wholesale distributorships featuring biopharmaceutical products; retail store services featuring biopharmaceutical products; business intermediary services in the field of biopharmaceutical products

[ Rental of medical and health care equipment; medical product information, namely, providing an interactive holistic web site featuring health information and patient initiated, patient authorized, fee-for-service, holistic approach distance healing sessions based on the patient's specific set of symptoms, medical profile and medical record analysis and patient benefit information concerning organic and holistic products and services; medical clinics, namely, conducting clinical trials of new products for medical purposes; hospitals; medical assistance services; biopharmaceutical consulting service ]

Pharmaceutical research and development; [ bacteriological research; biological research; research and development for new products for others; material testing; chemistry services, namely, chemistry consultation; chemical research and analysis; technology outsourcing services on biopharmaceuticals manufacturing, namely, conducting biopharmaceutical research services for others; consulting services in the field of biotechnology; pharmaceutical drug development services with animal cell; scientific research related to genetically modified plant; biotechnology research; ] biopharmaceutical research and development [ ; medical product testing; technology outsourcing services on selecting medicines, namely, conducting pharmaceutical research services for others ]

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 21, 2023 ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 2, 2022 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Jul 9, 2021 NREP
CHANGE OF OWNER RECEIVED FROM IB
Jun 12, 2021 CHLD
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Apr 1, 2021 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Apr 1, 2021 C75A
TEAS SECTION 71 & 15 RECEIVED
Mar 24, 2021 ES75
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 22, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 22, 2021 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Mar 22, 2021 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 22, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 22, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 22, 2021 COAR
NEW REPRESENTATIVE AT IB RECEIVED
Feb 12, 2021 NREP
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Mar 29, 2020 REM4
INTERNATIONAL REGISTRATION RENEWED
Dec 5, 2019 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Apr 6, 2018 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 21, 2018 INPS
INVALIDATION PROCESSED
Feb 21, 2018 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 15, 2018 INPR
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jul 31, 2017 LIMN
LIMITATION OF GOODS RECEIVED FROM IB
Jul 14, 2017 LIMG
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jun 15, 2017 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Jun 15, 2017 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 15, 2017 APRE
TEAS SECTION 71 RECEIVED
Mar 28, 2017 ES71
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 26, 2015 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 25, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 30, 2011 FICS
FINAL DISPOSITION PROCESSED
Jun 30, 2011 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 29, 2011 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 29, 2011 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 11, 2011 NPUB
PUBLISHED FOR OPPOSITION
Jan 11, 2011 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 7, 2010 PREV
ASSIGNED TO LIE
Dec 7, 2010 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 15, 2010 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 12, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 11, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 11, 2010 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 11, 2010 TCCA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 12, 2010 GNRN
NON-FINAL ACTION E-MAILED
May 12, 2010 GNRT
NON-FINAL ACTION WRITTEN
May 12, 2010 CNRT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 10, 2010 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 10, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 10, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 10, 2010 TROA
REFUSAL PROCESSED BY IB
Apr 30, 2010 RFNT
UNDELIVERABLE MAIL - NO ACTION TAKEN
Apr 19, 2010 UNDN
APPLICATION FILING RECEIPT MAILED
Mar 19, 2010 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 18, 2010 RFCS
REFUSAL PROCESSED BY MPU
Mar 18, 2010 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 18, 2010 RFCR
NON-FINAL ACTION WRITTEN
Mar 17, 2010 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Mar 17, 2010 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 17, 2010 RFCR
NON-FINAL ACTION WRITTEN
Mar 16, 2010 CNRT
ASSIGNED TO EXAMINER
Mar 15, 2010 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 15, 2010 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 11, 2010 REPR